Mkts

MacroGenics, Inc.

NASDAQ: MGNX
$2.33-0.07 (-2.92%)
As of Nov 2, 4:00 PM ET

Key statistics

Day range
2.322.54
52-week range
1.295.08
Today
Open2.41
Previous close2.33
Volume—
Valuation
Market cap152.88M
P/E ratio—
EPS (TTM)-0.23
Income & risk
Dividend / yield—
Beta1.31
Avg volume816.6K
Discussion

MGNX News

Stories mentioning MGNX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,77541,22872,83922,24113,19219,353110,70810,797
Cost of Goods Sold0.000.000.000.00233.00168.00176.00
Gross Profit41,22872,83922,24113,19219,120110,54010,621
Operating Expenses
Research & Development34,97433,97432,70940,79139,69838,89040,54351,732
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(33,439)(12,095)18,636(36,758)(42,624)(52,838)54,191(58,181)
Interest Income
Interest Expense4,8893,342802.0091.00(24.00)0.006.00
Other Expense
Pretax Income16,822(36,146)56,309(55,664)
Tax Provision0.00105.000.000.00
Net Income (Loss)(36,774)(14,155)16,822(36,251)(41,036)(15,421)56,309(55,664)
Earnings Per Share (Basic)(0.58)(0.22)0.27(0.57)(0.65)(0.25)0.90(0.89)
Earnings Per Share (Diluted)(0.58)(0.22)0.27(0.57)(0.65)(0.25)0.90(0.89)
Weighted Average Shares Outstanding (Basic)63,45063,15563,23363,13662,96562,62162,74462,664
Weighted Average Shares Outstanding (Diluted)63,45063,15563,28463,13662,96562,62162,86662,664

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MGNX

MacroGenics, Inc. (NASDAQ: MGNX) is a stock listed on the Nasdaq Stock Market under the ticker symbol MGNX. It last traded at $2.33 (Nov 2, 2026, 4:00 PM ET), down 2.9% on the day. That gives MacroGenics a market capitalisation of $152.9M.

Over the past 52 weeks MGNX has traded between $1.29 and $5.08.

Revenue for the quarter ended Mar 31, 2026 was $20.8M; a net loss of $36.8M. Revenue was up 57.5% from $13.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.8M-$36.8M-177.0%
Dec 31, 2025$41.2M-$14.2M-34.3%
Sep 30, 2025$72.8M$16.8M23.1%
Jun 30, 2025$22.2M-$36.3M-163.0%

From MacroGenics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…